Joint Development of Technologies for Longevity, Aging, and Regenerative Medicine

Commercialization of Sturgeon-Derived Biomaterials

Collaboration on Preclinical Research for Tissue Regeneration and Wound Healing

Hallym University Chuncheon Sacred Heart Hospital announced on the 22nd that it has signed a Memorandum of Understanding (MOU) with Almascavia Co., Ltd. to collaborate on research into longevity and aging, as well as the development of regenerative medical technologies using biological resources derived from sturgeon.


Personnel from Hallym University Chuncheon Sacred Heart Hospital and Almascavia Co., Ltd. are taking a commemorative photo after signing a memorandum of understanding (MOU) for the development of longevity and aging research and regenerative medical technologies utilizing bioresources derived from sturgeons. Hallym University Chuncheon Sacred Heart Hospital

Personnel from Hallym University Chuncheon Sacred Heart Hospital and Almascavia Co., Ltd. are taking a commemorative photo after signing a memorandum of understanding (MOU) for the development of longevity and aging research and regenerative medical technologies utilizing bioresources derived from sturgeons. Hallym University Chuncheon Sacred Heart Hospital

View original image

The two institutions plan to link their research competencies and technologies to conduct joint research in the fields of longevity and aging, tissue regeneration, and bio-health. They will also cooperate in the commercialization of research results and the transfer of technologies.


Under the agreement, both parties will jointly pursue: ▲ Research into the mechanisms of longevity and aging and the development of well-aging technologies based on sturgeon-derived cells ▲ Discovery of bioactive compounds and development of composite biomaterials for tissue regeneration ▲ Efficacy assessment and preclinical studies for tissue regeneration, wound healing, and promotion of healthy lifespan ▲ Identification of biomarkers and functional substances related to longevity, aging, and tissue regeneration ▲ Commercialization and technology transfer of research findings.


In addition, both sides will share research facilities, equipment, and data, and expand academic and technological exchanges to strengthen their competitiveness in regenerative medicine and the bio-health sector.



Lee Jaejun, Director of Hallym University Chuncheon Sacred Heart Hospital, stated, "By combining the hospital's clinical and research capabilities with the company's biomaterial technology, this will serve as an opportunity to establish a new research model for regenerative medicine," adding, "We will work together to deliver tangible research outcomes in the areas of longevity, aging, and tissue regeneration."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing